KIORA PHARMACEUTICALS, INC. Cash and Restricted Cash
KIORA PHARMACEUTICALS, INC. (KPRX) had Cash and Restricted Cash of $7.08 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.08M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.96M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.70M; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $8.70M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.51M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $7.08M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $10.96M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $8.70M 10-Q · filed 2026-08-07 | $8.70M 10-K · filed 2026-03-25 |
| 2025-09-30 | $5.51M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.03M 10-Q · filed 2026-08-07 | $1.03M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $3.78M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $3.80M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $5.64M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $6.58M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $31.28M 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $2.46M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $5.40M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $7.96M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $3.43M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $6.01M 10-K · filed 2025-03-25 | |
| 2022-09-30 | $4.85M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $2.48M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $5.11M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $7.90M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $11.15M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $3.71M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $6.66M 10-Q · filed 2022-07-08 | |
| 2020-12-31 | $1.23M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $2.98M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $4.73M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $5.92M 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $3.82M 10-K/A · filed 2022-07-07 | |
| 2019-09-30 | $2.50M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $4.51M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $5.90M 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $8.05M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $9.95M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $12.65M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $3.69M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $7.85M 10-K · filed 2020-03-04 | |
| 2017-09-30 | $9.24M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $11.81M 10-Q · filed 2018-08-03 | |
| 2017-03-31 | $5.48M 10-Q · filed 2018-05-11 | |
| 2016-12-31 | $3.68M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $8.41M 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |